Brain imaging a likely focus for ‘AI vs. mental illness’ researchers

Researchers in Canada have received more than a quarter million federal dollars to develop AI models for diagnosing and treating mental illness. One application in their sights involves automated interpretations of brain scans.

Based at the University of Alberta, the team will draw from more than 40 years of experience with AI and machine learning in the school’s computing science department, according to a U of A news item.

Computational psychiatry professor Bo Cao, PhD, says the plan is to tap the technology for personalizing care of patients with depression, bipolar disorder, schizophrenia and other conditions.

“That’s actually the ultimate goal,” he says. “We’re not there yet, but we are on a promising path.”

The work is one of 16 U of A projects receiving a share of $3.4 million in funding from the Canadian Foundation for Innovation, according to the school.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.